Clinical Trial Update: Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating CM082 in combination with paclitaxel as second-line therapy for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CM082
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AnewPharma | Conditions: Advanced Gastric Cancer | Phase 1 | Status: UNKNOWN